Zohreh.Gh
@ZohrehGh7
Followers
481
Following
7K
Media
33
Statuses
504
MD || Postdoctoral Researcher || IM-bound | Nephrology Aspirant ||
California, USA
Joined September 2020
Presenting the data on ALXN2050 in Lupus Nephritis: A phase 2 trial #ASN #Nephrology #ClinicalTrials @ASNKidney
1
9
54
🌟 An honor to mentor the next generation of leaders — so proud of all the incredible work you’re doing! Keep inspiring and pushing boundaries. 👏 #Mentorship #Kidneyweek #FutureLeaders #ProudMentor
2
4
34
Outstanding session on Hot topics in LupusNephritis. Covered it all, from next-gen treatment targets to complement inhibition. Fantastic lineup moderated by Dr. @SaynaNorouzi and Dr. Mejia-Vilet. #KidneyWk
1
18
75
2
2
29
‼️Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? https://t.co/1bBaoGNRLo
#KidneyCheck #CKD #Screening #KidneyDisease #PublicHealth #Kidneys
@KIReports @edgarvlermamd @rahaai @IGANFoundation
kireports.org
Nearly 850 million individuals around the world are estimated to have kidney disease.1 Chronic kidney disease (CKD), which is defined as structural or functional kidney abnormalities for ≥ 3 months,...
2
7
23
Trying to catch up with #IgAN trials⁉️ Check out ✅ “IgAN: An Overview of the Clinical Trials” ca. 2025 from @KidneyMed @ZohrehGh7 @haresh11 @NWiegley @Alexgr23 @rahaai @SaynaNorouzi @JEGAYTAN90
#Nephpearls #KidneyWk 👉 https://t.co/TWo6MpOtH9
0
23
47
We recently published on @KIReports on venous thromboembolism prevention in Nephrotic Syndrome addressing a significant and often underrecognized clinical issue in nephrology. https://t.co/5OQOpozHrA Building on this work, we conducted a follow-up survey to capture real-world
2
12
43
Trying to catch up with #IgAN trials⁉️ Check out “IgAN: An Overview of the Clinical Trials” ca. 2025 from @KidneyMed @ZohrehGh7 @haresh11 @NWiegley @Alexgr23 @rahaai @SaynaNorouzi @JEGAYTAN90
#Nephpearls #RKDSummit 👉 https://t.co/TWo6MpP1wH
0
12
26
Treatment targets 🎯 in IgA Nephropathy #IgAN and the positioning of drugs ca. 2025 from @goKDIGO
#Nephpearls #RKDSummit 📌 Proteinuria >/= 0.5 g/day (or equivalent) ~ at risk of progressive loss of kidney function 👉🏼 https://t.co/MFlu0Bb3oW
1
14
44
In our most recent article, we discuss indications, long-term use, complications and research gaps of rituximab in glomerular diseases. A special thank you to Drs Gameiro, Domingues and Windpessl for their fine contributions https://t.co/pqw2KjqeY3
4
37
107
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @KidneyMed @ZohrehGh7 @haresh11 @NWiegley @Alexgr23 @rahaai @SaynaNorouzi @JEGAYTAN90
#Nephpearls 👉 https://t.co/aYakhO8cvX
2
48
136
Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟 Together, our community can achieve so much; this is truly an exciting time for the #Nephrology field. We deeply appreciate and value your
2
12
61
Finale vibes at #GlomConHawaii 2025: KDIGO guidelines under the microscope with some of the sharpest minds on stage. @GlomCon
0
3
14
“Pregnancy is a stress test for kidneys” Oral abstracts by @hjanders_hans ⭐️🙌🏻 #GlomConHawaii @GlomCon
1
11
35
GN Clinic and Centers of Excellence: A Roundtable Discussion of Pros/Cons and the Future of GN Care A very interesting initiative to define specialized GN Centers of Excellence. amazingly presented by Dr. Norouzi and Dr. Gholizadeh @SaynaNorouzi @ZohrehGh7 #glomconhawaii
0
6
17
“FSGS is a lesion” -Dr. Fervenza @fervenzafernan1 @MayoClinicNeph Podocythopathies session in progress… #GlomConHawaii @GlomCon
3
3
23
Dr. Fervenza starts his lecture with “We all know that FSGS is not a disease, it’s a biopsy finding” #GlomConHawaii @GlomCon
2
11
65